EE03592B1 - Proliposoomi pulbrid inhaleerimiseks - Google Patents
Proliposoomi pulbrid inhaleerimiseksInfo
- Publication number
- EE03592B1 EE03592B1 EE9700134A EE9700134A EE03592B1 EE 03592 B1 EE03592 B1 EE 03592B1 EE 9700134 A EE9700134 A EE 9700134A EE 9700134 A EE9700134 A EE 9700134A EE 03592 B1 EE03592 B1 EE 03592B1
- Authority
- EE
- Estonia
- Prior art keywords
- inhalation
- proliposome powders
- proliposome
- powders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9404466A SE9404466D0 (sv) | 1994-12-22 | 1994-12-22 | Process for the preparation of powders for inhalation |
SE9502369A SE9502369D0 (sv) | 1995-06-30 | 1995-06-30 | Process for the preparation of compositions for inhalation |
PCT/SE1995/001560 WO1996019199A1 (fr) | 1994-12-22 | 1995-12-20 | Poudres de proliposome pour inhalations |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9700134A EE9700134A (et) | 1997-12-15 |
EE03592B1 true EE03592B1 (et) | 2002-02-15 |
Family
ID=26662194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9700134A EE03592B1 (et) | 1994-12-22 | 1995-12-20 | Proliposoomi pulbrid inhaleerimiseks |
Country Status (32)
Country | Link |
---|---|
US (1) | US6045828A (fr) |
EP (1) | EP0800383B1 (fr) |
JP (1) | JPH10510830A (fr) |
KR (1) | KR100432461B1 (fr) |
CN (1) | CN1087932C (fr) |
AR (1) | AR002009A1 (fr) |
AT (1) | ATE240095T1 (fr) |
AU (1) | AU693632B2 (fr) |
BR (1) | BR9510512A (fr) |
CA (1) | CA2208517A1 (fr) |
CZ (1) | CZ286469B6 (fr) |
DE (1) | DE69530792T2 (fr) |
DK (1) | DK0800383T3 (fr) |
EE (1) | EE03592B1 (fr) |
EG (1) | EG23683A (fr) |
ES (1) | ES2194931T3 (fr) |
FI (1) | FI972653A (fr) |
HU (1) | HUT77628A (fr) |
IL (1) | IL116454A (fr) |
IS (1) | IS1978B (fr) |
MY (1) | MY114114A (fr) |
NO (1) | NO320434B1 (fr) |
NZ (1) | NZ298180A (fr) |
PL (1) | PL184393B1 (fr) |
PT (1) | PT800383E (fr) |
RU (1) | RU2162689C2 (fr) |
SA (1) | SA95160463B1 (fr) |
SK (1) | SK284918B6 (fr) |
TR (1) | TR199501633A1 (fr) |
TW (1) | TW508248B (fr) |
UA (1) | UA43886C2 (fr) |
WO (1) | WO1996019199A1 (fr) |
Families Citing this family (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
US20020052310A1 (en) * | 1997-09-15 | 2002-05-02 | Massachusetts Institute Of Technology The Penn State Research Foundation | Particles for inhalation having sustained release properties |
TW497974B (en) * | 1996-07-03 | 2002-08-11 | Res Dev Foundation | High dose liposomal aerosol formulations |
WO1998011877A1 (fr) * | 1996-09-18 | 1998-03-26 | Dragoco, Inc. | Composition de poudre seche contenant un principe actif encapsule dans des liposomes |
US20030203036A1 (en) * | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
ID23192A (id) * | 1997-06-27 | 2000-03-23 | Astra Ab | Bubuk proliposoma untuk penghirupan yang distabilisasi oleh tokoferol |
PL337722A1 (en) * | 1997-06-27 | 2000-08-28 | Astra Ab | Novel combination antiasthmatic drugs |
US7052678B2 (en) * | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
US6090407A (en) | 1997-09-23 | 2000-07-18 | Research Development Foundation | Small particle liposome aerosols for delivery of anti-cancer drugs |
US7348025B2 (en) | 1997-09-23 | 2008-03-25 | Research Development Foundation | Small particle liposome aerosols for delivery of anticancer drugs |
US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
SE9704833D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New formulation |
US6956021B1 (en) * | 1998-08-25 | 2005-10-18 | Advanced Inhalation Research, Inc. | Stable spray-dried protein formulations |
EP1839648A3 (fr) * | 1998-11-12 | 2007-11-21 | Transave, Inc. | Système d'inhalation |
IL143046A0 (en) * | 1998-11-12 | 2002-04-21 | Pilkiewicz Frank G | An inhalation system |
GB9912639D0 (en) * | 1999-05-28 | 1999-07-28 | Britannia Pharmaceuticals Ltd | Improvements in and relating to treatment of respiratory conditions |
JP3840515B2 (ja) * | 1998-11-26 | 2006-11-01 | ブリタニア・ファーマスーティカルズ・リミテッド | 界面活性リン脂質を含む抗喘息の組合せ |
SI1158958T1 (sl) * | 1999-03-05 | 2007-10-31 | Chiesi Farma Spa | Izboljĺ ani praĺ kasti farmacevtski sestavki za inhalacijo |
EP1043016B1 (fr) * | 1999-03-30 | 2014-08-20 | Sodic Sa | Extrait de plante à base de glycérides, phospholipides et phytosphingolipides, son procédé de préparation et compositions cosmétiques le renfermant |
DE60026982T2 (de) * | 1999-04-05 | 2006-11-16 | Mannkind Corp., Danbury | Verfahren zur bildung von feinem pulver |
IL146132A0 (en) | 1999-05-27 | 2002-07-25 | Euro Celtique Sa | Preparations for the application of anti-infective and/or anti-inflammatory agents to external or internal parts of the human or animal body in functional and cosmetic tissue remodelling and repair treatments |
US7300667B1 (en) | 1999-05-27 | 2007-11-27 | Euro-Celtique, S.A. | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US20010036481A1 (en) * | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
US6749835B1 (en) | 1999-08-25 | 2004-06-15 | Advanced Inhalation Research, Inc. | Formulation for spray-drying large porous particles |
WO2001013891A2 (fr) * | 1999-08-25 | 2001-03-01 | Advanced Inhalation Research, Inc. | Modulation de liberation a partir de formulations seches en poudre |
US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
GB9928311D0 (en) * | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
DE10012151A1 (de) * | 2000-03-13 | 2001-09-27 | Gsf Forschungszentrum Umwelt | Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD |
GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
DK1337240T4 (en) * | 2000-11-30 | 2015-01-05 | Vectura Ltd | A process for the preparation of particles for use in a pharmaceutical composition |
US20020141946A1 (en) * | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
WO2003043585A2 (fr) * | 2001-11-20 | 2003-05-30 | Advanced Inhalation Research, Inc. | Compositions particulaires ameliorees destinees a etre administrees par voie pulmonaire |
US7368102B2 (en) | 2001-12-19 | 2008-05-06 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
NZ534142A (en) * | 2002-01-21 | 2007-08-31 | Vasogen Ireland Ltd | Pharmaceutically acceptable phosphate-glycerol carrying bodies comprising phospatidylglycerol and/or phosphatidylcholine and/or phosphatidylglycerol |
CA2477979A1 (fr) * | 2002-03-05 | 2003-09-18 | Transave, Inc. | Systeme d'inhalation pour le traitement d'infections intracellulaires |
DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
KR101301653B1 (ko) * | 2002-10-29 | 2013-08-30 | 트랜세이브, 인코포레이티드 | 항감염제의 지속적인 방출 |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
CN1208052C (zh) | 2003-03-20 | 2005-06-29 | 上海家化联合股份有限公司 | 一种辅酶q10前体脂质体及其制备方法 |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
CA2522158C (fr) * | 2003-04-14 | 2018-03-20 | Vectura Ltd. | Dispositifs et compositions pharmaceutiques destines a ameliorer l'efficacite du dosage |
US20060147389A1 (en) * | 2004-04-14 | 2006-07-06 | Vectura Ltd. | Devices and pharmaceutical compositions for enhancing dosing efficiency |
CN100427064C (zh) * | 2003-04-16 | 2008-10-22 | 沈阳药科大学 | 一种制备脂质体的新方法 |
DE602004031459D1 (de) * | 2003-09-02 | 2011-03-31 | Norton Healthcare Ltd | Verfahren zur herstellung eines medikaments |
WO2005044226A2 (fr) * | 2003-11-04 | 2005-05-19 | Nectar Therapeutics | Formulations de lipides pour l'encapsulation de medicaments |
EP1786784B1 (fr) | 2004-08-20 | 2010-10-27 | MannKind Corporation | Catalyse de la synthese de dicetopiperazine |
CA2578175C (fr) | 2004-08-23 | 2014-10-14 | Mannkind Corporation | Sels de dicetopiperazine, sels de dicetomorpholine ou sels de dicetodioxane permettant l'administration de medicaments |
GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
US7803404B2 (en) | 2005-09-14 | 2010-09-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
CA2838111C (fr) | 2005-12-08 | 2016-01-19 | Insmed Incorporated | Compositions a base de lipide d'anti-infectieux pour traiter des infections pulmonaires et procedes d'utilisation de celles-ci |
BRPI0707991B8 (pt) | 2006-02-22 | 2021-05-25 | Mannkind Corp | métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco |
CN1895223B (zh) * | 2006-04-05 | 2012-06-27 | 沈阳药科大学 | 一种新的脂质体制备方法 |
US9814672B2 (en) * | 2007-03-09 | 2017-11-14 | Susan T. Laing | Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi |
WO2008114274A1 (fr) * | 2007-03-19 | 2008-09-25 | Fresenius Kabi Onclology Ltd. | Compositions proliposomales et liposomales |
US20100196455A1 (en) | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US20090047336A1 (en) * | 2007-08-17 | 2009-02-19 | Hong Kong Baptist University | novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
EP2570147B1 (fr) | 2008-06-13 | 2017-10-18 | MannKind Corporation | Inhalateur de poudre sèche et système d'administration de médicament |
US9364619B2 (en) | 2008-06-20 | 2016-06-14 | Mannkind Corporation | Interactive apparatus and method for real-time profiling of inhalation efforts |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
EP3578169B1 (fr) | 2009-02-26 | 2024-06-26 | Glaxo Group Limited | Préparations pharmaceutiques comprenant 4-{(1r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]éthoxy}hexyl)amino]-1-hydroxyéthyl}-2-(hydroxyméthyl)-phénol |
PL2405963T3 (pl) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Urządzenie, układ i sposób pomiaru oporu inhalatora |
KR20180079458A (ko) | 2009-06-12 | 2018-07-10 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
EP2496295A1 (fr) | 2009-11-03 | 2012-09-12 | MannKind Corporation | Appareil et méthode de simulation d'efforts d'inhalation |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
CN105667994B (zh) | 2011-04-01 | 2018-04-06 | 曼金德公司 | 用于药物药盒的泡罩包装 |
WO2012174472A1 (fr) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | Microparticules de dicétopipérazine de capacité élevée |
AU2012328885B2 (en) | 2011-10-24 | 2017-08-31 | Mannkind Corporation | Methods and compositions for treating pain |
KR102277921B1 (ko) | 2012-05-21 | 2021-07-14 | 인스메드 인코포레이티드 | 폐 감염을 치료하기 위한 시스템 |
CN108057154B (zh) | 2012-07-12 | 2021-04-16 | 曼金德公司 | 干粉药物输送系统和方法 |
CA2878624C (fr) | 2012-08-17 | 2021-03-02 | Smartek International Llc | Preparation de liposomes desseches utilisable dans des systemes d'administration compressibles |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
EP3581186A1 (fr) | 2012-11-29 | 2019-12-18 | Insmed Incorporated | Formulations de vancomycine stabilisées |
US9603799B2 (en) * | 2013-03-15 | 2017-03-28 | Htd Biosystems Inc. | Liposomal vaccine adjuvants and methods of making and using same |
CA2906817C (fr) | 2013-03-15 | 2022-01-18 | Mannkind Corporation | Compositions de dicetopiperazine microcristallines et procedes |
US9925144B2 (en) | 2013-07-18 | 2018-03-27 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
JP2016530930A (ja) | 2013-08-05 | 2016-10-06 | マンカインド コーポレイション | 通気装置及び方法 |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
WO2017194454A1 (fr) * | 2016-05-09 | 2017-11-16 | Astrazeneca Ab | Nanoparticules lipidiques comprenant des agents anti-inflammatoires lipophiles et leurs procédés d'utilisation |
EP3773505A4 (fr) | 2018-03-30 | 2021-12-22 | Insmed Incorporated | Procédés pour la fabrication continue de produits médicamenteux liposomaux |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US514674A (en) * | 1894-02-13 | Ejector for breakdown guns | ||
DE2966795D1 (en) * | 1978-10-12 | 1984-04-19 | Bowater Scott Ltd | Holder and dispenser for stacked rolls |
GB2135647A (en) * | 1983-02-15 | 1984-09-05 | Squibb & Sons Inc | Method of preparing liposomes and products produced thereby |
US4744989A (en) * | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
DE3585967D1 (de) * | 1984-03-08 | 1992-06-11 | Phares Pharma Holland | Liposombildende zusammensetzung. |
SE8601457D0 (sv) * | 1986-04-01 | 1986-04-01 | Draco Ab | Compositions of liposomes and b?712-receptor active substances for inhalation |
SE8603812D0 (sv) * | 1986-09-12 | 1986-09-12 | Draco Ab | Administration of liposomes to mammals |
US5096629A (en) * | 1988-08-29 | 1992-03-17 | 501 Nippon Fine Chemical Co., Ltd. | Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes |
CA2087902C (fr) * | 1992-02-05 | 2006-10-17 | Narendra Raghunathji Desai | Compositions liposomiques renfermant des photosensibilisateurs a base de porphyrine |
CA2168656C (fr) * | 1993-08-06 | 2007-09-18 | Yechezkel Barenholz | Methode de preparation de vesicules chargees de structures biologiques, de biopolymeres et (ou) d'oligomeres |
US5635206A (en) * | 1994-01-20 | 1997-06-03 | Hoffmann-La Roche Inc. | Process for liposomes or proliposomes |
AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
-
1995
- 1995-12-18 AR ARP950100614A patent/AR002009A1/es unknown
- 1995-12-18 SA SA95160463A patent/SA95160463B1/ar unknown
- 1995-12-19 TW TW084113555A patent/TW508248B/zh not_active IP Right Cessation
- 1995-12-19 IL IL11645495A patent/IL116454A/en not_active IP Right Cessation
- 1995-12-20 CZ CZ19971948A patent/CZ286469B6/cs not_active IP Right Cessation
- 1995-12-20 CN CN95196978A patent/CN1087932C/zh not_active Expired - Fee Related
- 1995-12-20 DE DE69530792T patent/DE69530792T2/de not_active Expired - Lifetime
- 1995-12-20 SK SK814-97A patent/SK284918B6/sk unknown
- 1995-12-20 PT PT95942357T patent/PT800383E/pt unknown
- 1995-12-20 WO PCT/SE1995/001560 patent/WO1996019199A1/fr active IP Right Grant
- 1995-12-20 AT AT95942357T patent/ATE240095T1/de not_active IP Right Cessation
- 1995-12-20 PL PL95320825A patent/PL184393B1/pl not_active IP Right Cessation
- 1995-12-20 AU AU43605/96A patent/AU693632B2/en not_active Ceased
- 1995-12-20 DK DK95942357T patent/DK0800383T3/da active
- 1995-12-20 MY MYPI95003994A patent/MY114114A/en unknown
- 1995-12-20 EP EP95942357A patent/EP0800383B1/fr not_active Expired - Lifetime
- 1995-12-20 JP JP8519738A patent/JPH10510830A/ja not_active Ceased
- 1995-12-20 EE EE9700134A patent/EE03592B1/xx not_active IP Right Cessation
- 1995-12-20 NZ NZ298180A patent/NZ298180A/xx unknown
- 1995-12-20 RU RU97112399/14A patent/RU2162689C2/ru not_active IP Right Cessation
- 1995-12-20 KR KR1019970704253A patent/KR100432461B1/ko not_active IP Right Cessation
- 1995-12-20 BR BR9510512A patent/BR9510512A/pt not_active IP Right Cessation
- 1995-12-20 HU HU9800352A patent/HUT77628A/hu unknown
- 1995-12-20 CA CA002208517A patent/CA2208517A1/fr not_active Abandoned
- 1995-12-20 ES ES95942357T patent/ES2194931T3/es not_active Expired - Lifetime
- 1995-12-20 UA UA97073873A patent/UA43886C2/uk unknown
- 1995-12-20 US US08/617,918 patent/US6045828A/en not_active Expired - Lifetime
- 1995-12-21 TR TR95/01633A patent/TR199501633A1/xx unknown
- 1995-12-21 EG EG106095A patent/EG23683A/xx active
-
1997
- 1997-06-06 IS IS4500A patent/IS1978B/is unknown
- 1997-06-19 NO NO19972847A patent/NO320434B1/no unknown
- 1997-06-19 FI FI972653A patent/FI972653A/fi not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03592B1 (et) | Proliposoomi pulbrid inhaleerimiseks | |
US5797392C1 (en) | Inhaler | |
DE69708327T2 (de) | Pulverinhalator | |
NO990272D0 (no) | Pulver-inhalator | |
IL122605A0 (en) | Inhaler | |
PL325233A1 (en) | Inhaler | |
PL327616A1 (en) | Inhaler | |
HUP9901316A3 (en) | Inhaler | |
PL334447A1 (en) | Inhaler | |
PL335690A1 (en) | Inhaler | |
GB9324250D0 (en) | Inhaler | |
PL335701A1 (en) | Inhaler | |
IS4263A (is) | Innúðatæki | |
IS4698A (is) | Innúðatæki | |
DK0830166T3 (da) | Inhalationsapparat | |
GB9312197D0 (en) | Inhaler | |
FI955464A (fi) | Jauheinhalaattorin erotusjärjestelmä | |
NO996439D0 (no) | Proliposompulvere for inhalering stabilisert med tokoferol | |
AU121902S (en) | Neckwear | |
FI964489A0 (fi) | Jauheinhalaattori | |
GB9425875D0 (en) | Inhaler | |
AU122352S (en) | Inhaler | |
SI0758911T1 (en) | Powder inhaler | |
AU123967S (en) | Housing for inhaler | |
CA73444S (en) | Inhaler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20081220 |